Loading organizations...
Loading organizations...
Novel antimicrobials targeting antibiotic-resistant microorganisms.
Santero Therapeutics has raised $8.6M across 1 funding round.
Santero Therapeutics has raised $8.6M in total across 1 funding round.
Santero Therapeutics has raised $8.6M in total across 1 funding round.
Santero Therapeutics's investors include Philippe De Backer, Newton Biocapital, Sambrinvest, SFPI-FPIM, Wallonie Entreprendre.
Santero Therapeutics has raised $8.6M across 1 funding round. Most recently, it raised $8.6M Series A in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 7, 2023 | $8.6M Series A | Philippe De Backer, Newton Biocapital | Sambrinvest, SFPI-FPIM, Wallonie Entreprendre |